Stock Market Wealth
Become A Wealth Machine
FIRST AMERICA, THEN THE WORLD: Lucas Birdsall on the Global Cannabis Explosion
Across the planet, the cannabis industry is rapidly expanding into new frontiers like we’ve never witnessed before. The U.S. midterm elections brought us three more states with legalized marijuana, and now believe it or not, 80 million Americans now have legal access to recreational marijuana, medical marijuana, or both.
But it’s not only happening in America: there are other regions of the world that are making inroads into the emerging marijuana market. To get the full picture of what’s going on with the global expansion of legalized cannabis, Wealth Research Group had a talk with Lucas Birdsall, a recognized authority on this topic.
One of Vancouver’s top corporate advisory consultants, Lucas Birdsall is a proud alumnus of the Beedie School of Business at Simon Fraser University, achieving concentrations in the Finance and Operations Management streams. Lucas has worked with top firms in legalized cannabis as well as IT and fintech.
Courtesy: Lucas Birdsall
Since we had the pleasure of speaking of Mr. Birdsall, Wealth Research Group took the opportunity to ask him where the money was flowing in the European legalized cannabis trade. According to Lucas Birdsall, Europe and especially Israel adopted CBD (cannabidiol) consumption very early – about ten years before America.
What we’re seeing now is mass CBD adoption across the European Union member states, according to Lucas Birdsall. When it comes to medical marijuana, we’re seeing major strides in Denmark, Portugal, and Greece. Particularly in Greece, there was recent legislation put together to legalize medial cannabis.
Greece has been a center of attention because they’re experiencing regulatory shifts on almost a weekly basis, according to Lucas Birdsall. In southern Europe and in Nordic countries, we’re seeing governments adopt pro-medical cannabis policies as a way to bolster tax revenues, spur job growth, and introduce new industries into the region.
Furthermore, according to Lucas Birdsall, CBD products are extremely popular in Europe because they’re regulated in the European Union below a specified CBD level as a natural food supplement; this allows people in Europe to easily purchase CBD products over the counter.
Another reason for the popularity of CBD products in Europe and worldwide, according to Lucas Birdsall, is because of the reports that CBD possesses tremendous health benefits: it’s been reported to have anti-inflammatory and anti-anxiety effects, and the world is constantly learning more about CBD as new trials are conducted and reports are released.
Other medical cannabis-friendly regions around the world, according to Lucas Birdsall, include Colombia, Uruguay, and South Africa. These regions are leveraging the burgeoning cannabis trade to generate revenues from taxes as well as create jobs and boost the local economy.
Also leveraging the power of the global legalized cannabis trade is an up-and-coming company known as ICC International Cannabis Corp. (CSE: WRLD & OTC: KNHBF). This is a unique company because it’s the only small-cap company with such a unique array of licenses in multiple regions of the world where cannabis is legally bought and sold.
As Lucas Birdsall explains it, International Cannabis Corp.’s vision and mission is to be the world’s first fully vertically integrated Cannabis Company. This means that the company will participate in every link in the cannabis value chain – supply lighting and fertilizers, hydroponics, cultivating cannabis and hemp, extracting CBD and THC oils, all the way to selling, distributing, and marketing the product to the end consumer.
Lucas got us excited about this truly multinational, vertically integrated company, and then he dropped a bombshell update: through Marathon Global, a fully owned subsidiary of International Cannabis Corp., ICC has an exclusive agreement with Cosmos Holdings, which has a footprint of more than 35,000 pharmacies across 16 different countries, primarily in the European Union.
Their exclusive agreement permits International Cannabis Corp. to be the sole supplier of cannabis and CBD products to Cosmos. This will act as ICC’s distribution arm, according to Lucas Birdsall, and will allow ICC access to the consumers of CBD and THC products in Europe and beyond.
It’s huge news, and extremely bullish for ICC International Cannabis Corp. and for WRLD/KNHBF stock. Wealth Research Group is giving ICC its highest rating and recommendation – you definitely need to check out this rare opportunity to capitalize on the legalized cannabis market, not just on a national but on an international scale.
Governments Have Amassed ungodly Debt Piles and Have Promised Retirees Unreasonable Amounts of Entitlements, Not In Line with Income Tax Collections. The House of Cards Is Set To Be Worse than 2008! Rising Interest Rates Can Topple The Fiat Monetary Structure, Leaving Investors with Less Than Half of Their Equity Intact!
Protect Yourself Now, By Building A Fully-Hedged Financial Fortress!
This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.
Never base any decision off of our emails. WealthResearchGroup.com stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. We have entered into a three year agreements with each of the companies mentioned in this email, receiving up to four hundred thousand each, as well as purchasing shares that we will not sell during an email marketing, all of our paid profiles are paid for directly by the companies. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say.
Please review our entire disclaimer at WealthResearchGroup.com/disclaimer